Vimarsana
Biggest News Aggregation in the World

Ankit Mangla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ankit Mangla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ankit Mangla Today - Breaking & Trending Today

Doctors Weigh Patient Goals Instead of 'Dictating' Melanoma Treatment - Vimarsana News

Doctors Weigh Patient Goals Instead of 'Dictating' Melanoma Treatment

An expert explained the importance of patient choice in treatment decisions for high-risk, resectable melanoma, based on their own treatment goals.

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma - Vimarsana News

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.

Conserving Supply of Personal Protective Equipment—A Call for Ideas - Vimarsana News

Conserving Supply of Personal Protective Equipment—A Call for Ideas

The editors of JAMA recognize the challenges, concerns, and frustration about the shortage of personal protective equipment (PPE) that is affecting the care of

Multispecialty Team Diagnoses and Removes Glomus Tumor - Vimarsana News

Multispecialty Team Diagnoses and Removes Glomus Tumor

A team of experts in various specialties diagnosed the glomus tumor that was causing a woman's 40-year-long severe pain. In a 30-min procedure, they excised the tumor and her pain, a new case study reports.

Some Reassurance on Neurologic Effects of Checkpoint Inhibitors - Vimarsana News

Some Reassurance on Neurologic Effects of Checkpoint Inhibitors

Other than headaches, neurologic adverse events fewer with ICIs than with chemotherapy